Gimsilumab
Gimsilumab (MORAb-022) is a humanized monoclonal antibody targeting granulocyte macrophage colony-stimulating factor for the study of COVID-19-induced inflammation and hypoxemia.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
C-Fms | SARS-CoV
CAS Number
1648796-29-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PO54612M2 100 µg
Epstein-Barr virus (Herpesvirus 4) EBV Glycoprotein gp350 / EBV GP350 Protein (His Tag)
Ask
View Details 
MBS7059862 Inquire
Recombinant Saccharomyces cerevisiae Calnexin homolog (CNE1) , partial
Ask
View Details MBS717114-01 0.02 mg (E-Coli)
Recombinant Human Nuclear nucleic acid-binding protein C1D
Ask
View Details